A recent report from CBRE, a real estate services firm, which analyzed U.S. tech employment over the past five years, listed the top 50 technology markets in the United States, but Providence was not one of them.
A Chinese drug manufacturer is investing $42 million in Nabsys, which recently completed a financial restructuring that allowed it to reopen in March after being out of business for nearly seven months.
IlluminOss Medical Inc. said Monday that it has completed enrollment in its first U.S. clinical trial toward U.S. Food and Drug Administration approval of its IlluminOss System, a minimally invasive system to repair bone fractures.
The Slater Technology Fund has invested nearly $40 million in local companies since its establishment in 1996. But with no allocation from the state, it must fund operations from money that could be used for further investments. Should the state allocate money back to the fund, something it has done up until the last two fiscal years?